Despite frequent interaction, the HCP-pharma relationship in cardiology often falls short of delivering meaningful value. For HCPs, increasing clinical complexity, limited time, and information overload have raised expectations. ... Read this blog

The growing inclusion of patient-centric practices has fundamentally reshaped how life sciences organizations define the value of insights. When acted on effectively, medical insights can shape priorities, inform evidence generation, refine protocols, and ultimately ensure that patient needs are reflected in clinical and real-world outcomes. ... Read this blog

Oncology conferences have become more than scientific gatherings, they are now strategic platforms for diagnostics companies. ... Read this blog

Though there have been spectacular advancements in the field of medical sciences over the past few decades, the healthcare crisis keeps emerging time and again. The pharmaceutical industry is rising to these challenges by developing new drugs, vaccines, and treatments, be it a pandemic or the growing prevalence of certain diseases and conditions. However, many other issues present numerous challenges for the industry. ... Read this blog